Efficacy in human liver slices and primary human HSCs, confirming dual metabolic and antifibrotic activity, supporting clinical translatability.

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Researchers at the University of British Columbia developed a reliable method to produce helper T cells from stem cells by ...

Shoplazza, a global commerce platform serving direct-to-consumer (DTC) brands, on January 7 announced the launch of Fulfillment by Shoplazza (FBS), a comprehensive fulfillment infrastructure designed ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Scientists at Stanford Medicine have reported a discovery that could change how arthritis and joint damage are treated. In experiments on animals and human tissue, researchers found that blocking a ...

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

Intelligent Living Begins with the Right Renovation Mindset Why luxury home renovation South Florida trends demand smart ...

From January 16th to 18th, the event you need to attend, arrives in Miami to help you execute the 2026 you want to achieve. A high-intensity experience, led by the renowned CORAL MUJAES, designed for ...

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...